Statistics

Total Visits

Views
Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab20

Select a period of time:

Number of views in the range

Views
Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab9

Views

Views
May 20244
June 20242
July 20240
August 20240
September 20241
October 20241
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
United Kingdom2
 

Top cities views

Views
Chicago2